Wim Ottevaere
Direktor/Vorstandsmitglied bei SEQUANA MEDICAL N.V.
Aktive Positionen von Wim Ottevaere
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SEQUANA MEDICAL N.V. | Direktor/Vorstandsmitglied | 08.11.2018 | - |
| Independent Dir/Board Member | 08.11.2018 | - |
Karriereverlauf von Wim Ottevaere
Ehemalige bekannte Positionen von Wim Ottevaere
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOTALYS NV | Finanzdirektor/CFO | 01.09.2018 | 01.07.2023 |
| ABLYNX | Finanzdirektor/CFO | 01.01.2006 | 01.09.2018 |
| Public Communications Contact | 05.04.2010 | 01.02.2011 | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Finanzdirektor/CFO | 01.01.1992 | 01.07.2006 |
| Fujirebio US, Inc. | Finanzdirektor/CFO | 01.01.1992 | 01.01.2006 |
Vanhout & Fils NV
 Vanhout & Fils NV HomebuildingConsumer Durables Part of Van Roey SA NV, Vanhout & Fils NV provides building and structural construction services. The company is based in Geel, Belgium. | Finanzdirektor/CFO | 01.01.1990 | 01.01.1992 |
Ausbildung von Wim Ottevaere
| University of Antwerp | Graduate Degree |
Statistik
International
| Belgien | 7 |
| Vereinigte Staaten | 2 |
Operativ
| Director of Finance/CFO | 5 |
| Public Communications Contact | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Durables | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOTALYS NV | Process Industries |
| SEQUANA MEDICAL N.V. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Vanhout & Fils NV
Vanhout & Fils NV HomebuildingConsumer Durables Part of Van Roey SA NV, Vanhout & Fils NV provides building and structural construction services. The company is based in Geel, Belgium. | Consumer Durables |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
| Fujirebio US, Inc. |
- Börse
- Insiders
- Wim Ottevaere
- Erfahrung
